Skip to main content
Article thumbnail
Location of Repository

CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract

By Jason M. Brenchley, Timothy W. Schacker, Laura E. Ruff, David A. Price, Jodie H. Taylor, Gregory J. Beilman, Phuong L. Nguyen, Alexander Khoruts, Matthew Larson, Ashley T. Haase and Daniel C. Douek

Abstract

The mechanisms underlying CD4+ T cell depletion in human immunodeficiency virus (HIV) infection are not well understood. Comparative studies of lymphoid tissues, where the vast majority of T cells reside, and peripheral blood can potentially illuminate the pathogenesis of HIV-associated disease. Here, we studied the effect of HIV infection on the activation and depletion of defined subsets of CD4+ and CD8+ T cells in the blood, gastrointestinal (GI) tract, and lymph node (LN). We also measured HIV-specific T cell frequencies in LNs and blood, and LN collagen deposition to define architectural changes associated with chronic inflammation. The major findings to emerge are the following: the GI tract has the most substantial CD4+ T cell depletion at all stages of HIV disease; this depletion occurs preferentially within CCR5+ CD4+ T cells; HIV-associated immune activation results in abnormal accumulation of effector-type T cells within LNs; HIV-specific T cells in LNs do not account for all effector T cells; and T cell activation in LNs is associated with abnormal collagen deposition. Taken together, these findings define the nature and extent of CD4+ T cell depletion in lymphoid tissue and point to mechanisms of profound depletion of specific T cell subsets related to elimination of CCR5+ CD4+ T cell targets and disruption of T cell homeostasis that accompanies chronic immune activation

Topics: Article
Publisher: The Rockefeller University Press
OAI identifier: oai:pubmedcentral.nih.gov:2211962
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2001). Analysis of total HIV-specific CD4 and CD8 T cell responses: relationship to viral load in untreated HIV infection.
    2. (1998). Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.
    3. (2000). cells: a right time and a right place for a conserved third way of protection.
    4. (1997). Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection.
    5. (2002). Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis.
    6. (2003). Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.
    7. (2001). Cutting edge: secondary lymphoid organs are essential for maintaining the CD4, but not CD8, naive T cell pool.
    8. (2000). Dynamics of CCR5 expression by CD4( ) T cells in lymphoid tissues during simian immunodeficiency virus infection.
    9. (2001). Early immunologic events in mucosal and systemic lymphoid tissues after intrarectal inoculation with simian immunodeficiency virus.
    10. (2000). Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue.
    11. (2002). Expansion of preexisting, lymph node-localized CD8 T cells during supervised treatment interruptions in chronic HIV-1 infection.
    12. (1995). Follicular dendritic cells and human immunodeficiency virus infectivity.
    13. (1992). Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4 T-helper cells.
    14. (1998). Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4 T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes.
    15. (1998). Gastrointestinal tract as a major site of CD4 T cell depletion and viral replication in SIV infection.
    16. (1997). Germinal centre CD4 T cells are an important site of HIV replication in vivo.
    17. (2002). Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. MMWR Recomm.
    18. (2003). Heterogeneity of the simian immunodeficiency virus (SIV) specific CD8 T-cell response in mucosal tissues during SIV primary infection. Microbes Infect.
    19. (1993). HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.
    20. (2002). HIV preferentially infects HIV-specific CD4 T-cells.
    21. (1999). HIV-1-specific CD4 T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression.
    22. (2003). Homing and cellular traffic in lymph nodes.
    23. (2000). Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation.
    24. (1998). Immune activation in the context of HIV infection.
    25. Increased turnover of CCR5 and redistribution of CCR5 CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.
    26. (1999). Initial increase in blood CD4 lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.
    27. (1998). Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1beta expression and display antiviral cytotoxic activity despite severe CD4 T-cell depletion in primary simian immunodeficiency virus infection.
    28. (1998). Kinetics of CD4 T cell repopulation of lymphoid tissues after treatment of HIV-1 infection.
    29. (1993). Loss of mucosal CD4 lymphocytes is an early feature of HIV infection.
    30. (1993). Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.
    31. (2003). Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system.
    32. (1993). New concepts in the immunopathogenesis of human imunodeficiency virus infection.
    33. (2003). Optimization of methods to assess human mucosal T-cell responses to HIV infection.
    34. (1997). Phenotypic and functional separation of memory and effector human CD8 T cells.
    35. (1999). Population biology of HIV-1 infection: viral and CD4 T cell demographics and dynamics in lymphatic tissues.
    36. (1997). Positive effects of combined antiretroviral therapy on CD4 T cell homeostasis and function in advanced HIV disease.
    37. (1996). Quantitative image analysis of HIV-1 infection in lymphoid tissue.
    38. (1999). Rapid mucosal CD4 T-cell depletion and enteropathy in simian immunodeficiency virusinfected rhesus macaques.
    39. (1997). Selective depletion of rectal lamina propria rather than lymphoid aggregate CD4 lymphocytes in HIV infection.
    40. (2003). Severe CD4 T-cell depletion in gut lymphoid tissue during primary hu-Brenchley et al. 759 man immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
    41. (2003). Simian immunodeficiency virus infection in neonatal macaques.
    42. (2003). T cell dynamics in HIV-1 infection.
    43. (2004). T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.
    44. (1997). The anatomical basis of intestinal immunity.
    45. (2004). The CCR5 and CXCR4 coreceptors-central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection.
    46. (2001). The mucosal immune system: primary target for HIV infection and AIDS. Trends Immunol.
    47. (1998). The unenlarged lymph nodes of HIV-1–infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy.
    48. (2003). Trafficking of human immunodeficiency virus type 1-specific CD8 T cells to gut-associated lymphoid tissue during chronic infection.
    49. (1999). Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.
    50. (2003). Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian–human immunodeficiency virus infection.
    51. (2003). Vaginal CD4 T cells express high levels of CCR5 and are rapidly depleted in simian immunodeficiency virus infection.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.